Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
Jeffrey Seow, Carl Graham, Blair Merrick, Sam Acors, Suzanne Pickering, Kathryn J. A. Steel, Oliver Hemmings, Aoife M. O’Byrne, Neophytos Kouphou, Rui Pedro Galão, Gilberto Betancor, Harry Wilson, Adrian W. Signell, Helena Winstone, Claire Kerridge, Isabella Huettner, Jose M. Jiménez-Guardeño, María José Lista, Nigel Temperton, Luke B. Snell, Karen Bisnauthsing, Amelia Moore, Adrian J. Green, Lauren Martinez, Brielle Stokes, Johanna Honey, Alba Izquierdo-Barras, Gill Arbane, Amita Patel, Mark Tan Kia Ik, Lorcan O’Connell, Geraldine O’Hara, Eithne MacMahon, Sam Douthwaite, Gaia Nebbia, Rahul Batra, Rocío T. Martínez-Nuñez, Manu Shankar‐Hari, Jonathan D. Edgeworth, Stuart J. D. Neil, Michael H. Malim, Katie J. Doores
Topics & Concepts
SeroconversionAntibodyNeutralizing antibodyImmunologyAntibody responseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyPopulationCoronavirus disease 2019 (COVID-19)MedicineBiologyDiseaseInternal medicineInfectious disease (medical specialty)Environmental healthSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing